NO914937L - Immunoaktive peptider og antistoffer samt deres anvendelse ved anti-allergibehandling - Google Patents

Immunoaktive peptider og antistoffer samt deres anvendelse ved anti-allergibehandling

Info

Publication number
NO914937L
NO914937L NO91914937A NO914937A NO914937L NO 914937 L NO914937 L NO 914937L NO 91914937 A NO91914937 A NO 91914937A NO 914937 A NO914937 A NO 914937A NO 914937 L NO914937 L NO 914937L
Authority
NO
Norway
Prior art keywords
histamine
peptide
phe
antibodies
allergy treatment
Prior art date
Application number
NO91914937A
Other languages
English (en)
Norwegian (no)
Other versions
NO914937D0 (no
Inventor
Denis Raymond Stanworth
Ian Victor Lewin
Sarita Nayyar
Valerie Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of NO914937D0 publication Critical patent/NO914937D0/no
Publication of NO914937L publication Critical patent/NO914937L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO91914937A 1989-06-15 1991-12-13 Immunoaktive peptider og antistoffer samt deres anvendelse ved anti-allergibehandling NO914937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898913737A GB8913737D0 (en) 1989-06-15 1989-06-15 A novel anti-allergy treatment
PCT/GB1990/000926 WO1990015878A1 (en) 1989-06-15 1990-06-15 Immunoactive peptides and antibodies and their use in anti-allergy treatment

Publications (2)

Publication Number Publication Date
NO914937D0 NO914937D0 (no) 1991-12-13
NO914937L true NO914937L (no) 1991-12-19

Family

ID=10658467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914937A NO914937L (no) 1989-06-15 1991-12-13 Immunoaktive peptider og antistoffer samt deres anvendelse ved anti-allergibehandling

Country Status (18)

Country Link
US (1) US5601821A (fi)
EP (2) EP0477231B1 (fi)
JP (2) JPH04505922A (fi)
KR (1) KR0181313B1 (fi)
AT (1) ATE122401T1 (fi)
CA (1) CA2057860C (fi)
DE (1) DE69019348T2 (fi)
DK (1) DK0477231T3 (fi)
ES (1) ES2073028T3 (fi)
FI (1) FI104723B (fi)
GB (2) GB8913737D0 (fi)
IE (1) IE71677B1 (fi)
NO (1) NO914937L (fi)
NZ (1) NZ234085A (fi)
PH (1) PH30233A (fi)
PT (1) PT94381B (fi)
WO (1) WO1990015878A1 (fi)
ZA (1) ZA904670B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトIgE モノクローナル抗体
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするdna
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
ES2180576T3 (es) * 1993-04-27 2003-02-16 United Biomedical Inc Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
WO1995026365A1 (en) * 1994-03-28 1995-10-05 United Biomedical, Inc. Synthetic peptide based immunogens for the treatment of allergy
GB9412714D0 (en) * 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
GB9416321D0 (en) * 1994-08-12 1994-10-05 Peptide Therapeutics Ltd Peptides and antibodies and their use in treatment of carcinomas
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
RU2193413C2 (ru) 1996-03-01 2002-11-27 Новартис Аг Пептидные иммуногены для вакцинации и лечения аллергии
EP0904031A4 (en) * 1996-05-29 2002-05-02 Cell Genesys Inc CATIONIC POLYMERS / LIPIDS AS VEHICLES FOR PROVIDING NUCLEIC ACID
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
EP2361635A3 (en) 2000-08-30 2011-09-14 Pfizer Products Inc. Anti IgE vaccines
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性IgEワクチン
ATE447967T1 (de) 2001-09-14 2009-11-15 Cytos Biotechnology Ag Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
NZ537688A (en) 2002-07-19 2007-01-26 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays for treating and/or attenuating Alzheimer's disease
US7425620B2 (en) 2002-08-14 2008-09-16 Scott Koenig FcγRIIB-specific antibodies and methods of use thereof
US20070218086A1 (en) 2004-04-26 2007-09-20 Innate Pharma, S.A. Adjuvant Composition and Methods for Its Use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
DK2032592T3 (da) 2006-06-12 2013-09-02 Cytos Biotechnology Ag Fremgangsmåder til pakning af oligonukleotider til virus-lignende partikler af rna-bakteriofager
ES2599319T3 (es) 2006-06-26 2017-02-01 Macrogenics, Inc. Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
AU2010217100B2 (en) * 2009-02-25 2014-03-27 Academia Sinica Anti-CepsilonmX antibodies capable of binding to human mIgE on B lymphocytes
CN104603150A (zh) 2012-04-20 2015-05-06 中央研究院 与CH4和CεmX结构域之间的连接处结合的抗mIgE抗体
CA3018114A1 (en) * 2016-03-18 2017-09-21 Genclis Molecular origin of allergy
EP3703753A4 (en) 2017-10-31 2021-08-18 Oneness Biotech Co., Ltd. TREATMENT OF IGE-MEDIATED ALLERGIC DISEASES
JP7503857B2 (ja) * 2022-04-11 2024-06-21 緑茵生技股▲ふん▼有限公司 抗アレルギー性ペプチド及びその免疫調節と抗アレルギーに用いられる用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
AU1484688A (en) * 1987-02-20 1988-09-14 Imclone Systems, Inc. Monoclonal antibodies in vaccine formulations
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
GB2246780B (en) * 1990-05-25 1994-04-27 Nat Res Dev Immunodiagnostic assay for rheumatoid arthritis
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
WO1990015878A1 (en) 1990-12-27
ATE122401T1 (de) 1995-05-15
KR920702723A (ko) 1992-10-06
JPH04505922A (ja) 1992-10-15
EP0477231B1 (en) 1995-05-10
NZ234085A (en) 1991-09-25
CA2057860C (en) 2000-05-09
EP0477231A1 (en) 1992-04-01
IE902154L (en) 1990-12-15
EP0403312A1 (en) 1990-12-19
US5601821A (en) 1997-02-11
DE69019348D1 (de) 1995-06-14
ZA904670B (en) 1992-02-26
FI104723B (fi) 2000-03-31
IE902154A1 (en) 1991-01-02
GB9013478D0 (en) 1990-08-08
IE71677B1 (en) 1997-02-26
GB8913737D0 (en) 1989-08-02
NO914937D0 (no) 1991-12-13
ES2073028T3 (es) 1995-08-01
JP2000152783A (ja) 2000-06-06
PT94381B (pt) 1996-11-29
AU5814890A (en) 1991-01-08
PT94381A (pt) 1991-02-08
CA2057860A1 (en) 1990-12-16
KR0181313B1 (ko) 1999-04-01
DE69019348T2 (de) 1995-09-21
AU646808B2 (en) 1994-03-10
FI915891A0 (fi) 1991-12-13
PH30233A (en) 1997-02-05
DK0477231T3 (da) 1995-07-10

Similar Documents

Publication Publication Date Title
NO914937L (no) Immunoaktive peptider og antistoffer samt deres anvendelse ved anti-allergibehandling
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
DK0751992T3 (da) Karendotelvækstfaktor 2
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
NO891711L (no) Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr.
MD1652F2 (en) Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
EP0831900A4 (en) METHOD FOR TRAINING ANTIBODIES AGAINST E. CS4CFA / 1 FAMILY PACKAGE
Jones et al. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity
Maoz et al. Immunological cross-reactions between the synthetic ordered polypeptide (L-Pro-Gly-L-Pro) n and several collagens
Talwar Immunobiology of gonadotropin-releasing hormone
DE69127974D1 (de) Peptide und deren verwendung
Jeffcoate et al. Preparation and specificity of antibodies to the decapeptide, luteinizing hormone-releasing hormone (LH-RH)
Das et al. Pregnancy interfering action of LHRH and anti-LHRH
Pestel et al. Polyclonal cell activity of a repeat peptide derived from the sequence of an 85-kilodalton surface protein of Trypanosoma cruzi trypomastigotes
EP0358485A3 (en) Human rhinovirus peptides
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ZA907944B (en) Hiv related peptides
IL115825A0 (en) Therapeutic protein
CA2386863C (en) Antigenic modification of polypeptides
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
WO1994014469A1 (en) Multivalent ab1 antibodies as vaccines
Hwang et al. Detection of cells producing murine interferon‐α using antipeptide antibodies
Rosenquist et al. The specificity of antibodies directed to porcine gastrin
KR970074790A (ko) 합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application